Charles River Laboratories International Intangible Assets

As of the most recent data (March 2026), CRL shows a intangible assets of $250M. That compares with $660M in the prior-year period — down 62.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CRL's intangible assets is now $250M (was $660M) — a 62.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Charles River Laboratories International is outperforming or lagging.

Tracking CRL's intangible assets over time shows whether Charles River Laboratories International is scaling, shrinking, or reshaping that part of the business. The current reading is $250M That compares with $660M in the prior-year period — down 62.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Charles River Laboratories International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $250M) with ownership activity and broader fundamentals.

Charles River Laboratories International's intangible assets is $250M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.